Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Eddingpharm to Distribute Breast Cancer Drug for GSK in China

09:38 EDT 9 Apr 2013 | ChinaBio Today

Eddingpharm, a Shanghai company, signed a collaboration agreement with GlaxoSmithKline China that gives Eddingpharm exclusive rights to market and distribute Tykerb in China. Tykerb was recently approved by the SFDA as a treatment for patients with H...

Original Article: Eddingpharm to Distribute Breast Cancer Drug for GSK in China

NEXT ARTICLE

More From BioPortfolio on "Eddingpharm to Distribute Breast Cancer Drug for GSK in China"

Search BioPortfolio: